ADVIA CENTAUR XPT CEA ASSAY N/A 10309977

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-03-09 for ADVIA CENTAUR XPT CEA ASSAY N/A 10309977 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[69572090] The cause for the discordant advia centaur xpt/xp cea result is unknown. Siemens healthcare diagnostics is investigating. The instruction for use (ifu) limitation section states: "warning: do not use the advia centaur cea immunoassay as a screening test for diagnosis. Note: do not interpret levels of cea as absolute evidence of the presence or the absence of malignant disease. Measurements of cea should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation. The concentration of cea in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods, calibration, and reagent specificity. Cea determined with different manufacturers' assays will vary depending on the method of standardization and antibody specificity. Warning: do not use the advia centaur cea immunoassay as a screening test for diagnosis. "
Patient Sequence No: 1, Text Type: N, H10


[69572091] A false low advia centaur xpt cea result was obtained on a patient sample. The patient noticed that the previous result was elevated for cea from the health check. The customer then ran the sample on an alternate method and the result was elevated. The patient sample was sent to another laboratory for testing on two alternate methods and the advia centaur xp. The results on the two alternate methods were elevated and the result on the advia centaur xp was low. It is unknown if patient treatment was altered or prescribed. There was no report of adverse health consequences due to the discordant advia centaur xp cea results.
Patient Sequence No: 1, Text Type: D, B5


[73486047] Siemens filed the initial mdr 1219913-2017-00060 on march 9, 2017. On 03/13/2017 additional information: the patient went for an endoscopy and no cancerous symptom was found. The normal result was reported to patient. The patient sample result on the advia centaur system was normal but elevated on the two alternate methods. The patient had an endoscopy performed and no issues were found. The alternate method 1 cea instructions for use (ifu) indicates that meconium antigen (nca2) interacts with the antibodies used in their assay. As stated in the ifu for the advia centaur cea assay, nca2 does not cross react with the assay. The alternate method 2 ifu does not mention whether nca2 cross reacts or not. It is possible this patient sample contains nca2 which is cross reacting with the alternate method assays. The cause for the discordant cea result id unknown. The patient sample was not available for evaluation at the manufacturing site. The instrument is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2017-00060
MDR Report Key6391472
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-03-09
Date of Report2017-03-31
Date of Event2017-02-17
Date Mfgr Received2017-03-13
Device Manufacturer Date2016-09-16
Date Added to Maude2017-03-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XPT CEA ASSAY
Generic NameCEA IMMUNOASSAY
Product CodeDHX
Date Received2017-03-09
Model NumberN/A
Catalog Number10309977
Lot Number167
Device Expiration Date2017-09-16
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2017-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.